NM_003060.4(SLC22A5):c.1055T>G (p.Met352Arg) AND Renal carnitine transport defect

Germline classification:: Uncertain significance (2 submissions)
Last evaluated:: Apr 12, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV000815094.11

Allele description [Variation Report for NM_003060.4(SLC22A5):c.1055T>G (p.Met352Arg)]

NM_003060.4(SLC22A5):c.1055T>G (p.Met352Arg)

Gene:

SLC22A5:solute carrier family 22 member 5 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

5q31.1

Genomic location:

Preferred name:

NM_003060.4(SLC22A5):c.1055T>G (p.Met352Arg)

HGVS:

NC_000005.10:g.132390692T>G
NG_008982.2:g.25989T>G
NM_001308122.2:c.1127T>G
NM_003060.4:c.1055T>GMANE SELECT
NP_001295051.1:p.Met376Arg
NP_003051.1:p.Met352Arg
NC_000005.9:g.131726384T>G
NM_003060.3:c.1055T>G

Protein change:

M352R

Links:

dbSNP: rs1275349783

NCBI 1000 Genomes Browser:

rs1275349783

Molecular consequence:

NM_001308122.2:c.1127T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_003060.4:c.1055T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Renal carnitine transport defect (CDSP)
Synonyms:: CARNITINE TRANSPORTER, PLASMA-MEMBRANE, DEFICIENCY OF; Primary carnitine deficiency; Carnitine uptake defect; See all synonyms [MedGen]
Identifiers:: MONDO: MONDO:0008919; MedGen: C0342788; Orphanet: 158; OMIM: 212140

Recent activity

Clear Turn Off Turn On

Homo sapiens ATP binding cassette subfamily B member 10 (ABCB10), mRNA; nuclear ...
Homo sapiens ATP binding cassette subfamily B member 10 (ABCB10), mRNA; nuclear gene for mitochondrial product
gi|1519245876|ref|NM_012089.3|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000955537	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Apr 12, 2023)	germline	clinical testing	PubMed (3) [See all records that cite these PMIDs] 10454528, 10559218, 28492532
SCV001462819	Natera, Inc.	no assertion criteria provided	Uncertain significance (Sep 16, 2020)	germline	clinical testing

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000955537

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Apr 12, 2023)

germline

clinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV001462819

Natera, Inc.

no assertion criteria provided

Uncertain significance
(Sep 16, 2020)

germline

clinical testing

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.

Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V.

J Pharmacol Exp Ther. 1999 Sep;290(3):1482-92.

PubMed [citation]

PMID:: 10454528

Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function.

Seth P, Wu X, Huang W, Leibach FH, Ganapathy V.

J Biol Chem. 1999 Nov 19;274(47):33388-92.

PubMed [citation]

PMID:: 10559218

See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000955537.6

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (3)

Description

An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant¬† is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects SLC22A5 function (PMID: 10454528, 10559218). ClinVar contains an entry for this variant (Variation ID: 658296). This variant has not been reported in the literature in individuals affected with SLC22A5-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces methionine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 352 of the SLC22A5 protein (p.Met352Arg).

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Natera, Inc., SCV001462819.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 8, 2024

ClinVar

Relating variation to medicine